youd think saving toes feet and legs from amputation and saving a patient amputee from mortality likely infection
would raise more than eyebrows
i reckon post cap raise once funded again this share willsoar back to levels see in 2021
ie 300 m ill mcap not an unrealistic valuation by start phase 11/111 i am pretty sure
Ann: Additional Positive Patient Cases - Special Access Scheme, page-7
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.0¢ |
Change
0.010(2.17%) |
Mkt cap ! $104.2M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 47.0¢ | 46.0¢ | $34.35K | 73.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 222366 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 42188 | 4 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| RCE (ASX) Chart |